Company intelligence / Profile preview

Magellan BioScience Group

Tampa, Florida, United States

Ownership: Private
Development stage: Other

Overview

Magellan BioScience Group develops proprietary media to isolate marine microbes and offers libraries of microbial extracts and synthetic peptides for research and screening; their compounds are intended as lead candidates for drug, agrochemical, enzyme, and specialty chemical development and have not reached clinical stages

Modalities: Small moleculePeptidesMicrobial natural product
Industry: Drug Discovery Services

Partnerships

Collaborations with research companies and academic centers across the U.S.

Beyond the preview

Go deeper on Magellan BioScience Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Magellan BioScience Group.

Explore the full profile